JPRN-UMIN000015495已完成未知
Clinical trial of tocilizumab for skin fibrosis in systemic sclerosis (Ver. Osaka) - Clinical trial of tocilizumab for skin fibrosis in systemic sclerosis (Ver. Osaka)
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients who are administered the other biologics 2)Patients who have history of anaphylactic reactions to this drug 3)Patients who have HBV or who are under the septic condition 4)significant liver damage 5)significant renal damage 6)possibility of tuberculosis 7)pregnancy 8)breast-feeding 9)participating in other clinical trial within three months before the beginni ng of this trial 10)judged inappropriate for this study by the physicians
研究者
相似试验
已完成
不适用
Clinical trial of tocilizumab for skin fobrosis in systemic sclerosisSystemic sclerosisJPRN-UMIN000012214The University of Tokyo5
进行中（未招募）
1 期
A study of Tocilizumab in patients with JIA associated Uveitis who have not responded to treatment with an anti-TNF.Juvenile Idiopathic Arthritis with Associated UveitisMedDRA version: 18.0 Level: PT Classification code 10046851 Term: Uveitis System Organ Class: 10015919 - Eye disordersMedDRA version: 18.0 Level: PT Classification code 10059176 Term: Juvenile idiopathic arthritis System Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2015-001323-23-GBniversity Hospitals Bristol NHS Foundation Trust21
已完成
不适用
Clinical trial of efficacy for tocilizumab in systemic sclerosis and sclerodermatous chronic GVHDThe patients with systemic sclerosis or sclerodermatous chronic GVHD.JPRN-UMIN000020389Kanazawa University Hospital, Department of dermatology5
已完成
不适用
Clinical trial of Tocilizumab for adult onset still diseaseJPRN-UMIN000012987Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine34
已完成
2 期
Clinical trial of tocilizumab for skin fibrosis in systemic sclerosisSystemic sclerosisJPRN-jRCTs031180370Yoshizaki Ayumi5